Skip to content

The effectiveness of steam inhalation and pistachio oil in treating migraine.

Efficacy of Inkibab and Saut of Roghan-i-Pista in Shaqiqa (Migraine) A Randomized placebo controlled, Assessor Blinded clinical trial. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080213
Enrollment
46
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: Inkibab (steam inhalation) followed by Saut (nasal instillation) of Roghan-i-Pista (pistachio oil). : In the Test group 2 drops of Roghan-i-Pista in each nostril, twice daily follow

Sponsors

National Institute of Unani Medicine, Bangalore
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient Diagnosed cases of Migraine (as per the International Classification of Headache Disorders (ICHD-3) 2.Patient having Pain intensity on the VAS scale between 3-7 3.Patients between the age of 18–50 years 4.Patients of any gender 5.Patients who will give consent and can do follow-up

Exclusion criteria

Exclusion criteria: 1.Patient use of any migraine prophylactic agents (b-blockers, anti-depressants, calcium channel blockers, anti-epileptic agents, cycle-modulating hormonal drugs, or vessel dilatation agents) within 1 month prior to screen 2.Patient having history or evidence of psychiatric disorder patients 3.Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
•Pain intensity –Migraine Disability Assessment (MIDAS) •Headache frequency and duration from the headache diaryTimepoint: Base Line,15th,30th,45th,60th

Secondary

MeasureTime frame
•Migraine-Specific Quality of Life Questionnaire version 2.1 (MSQv2.1)22Timepoint: Base Line,15th,30th,45th,60th

Countries

India

Contacts

Public ContactDr Abdul Azeez

National Institute Of Unani Medicine, Bangalore

aafaris@gmail.com9035417278

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026